• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎感染对中风、肺栓塞和心肌梗死发病的影响:一项回顾性研究

The Impact of COVID-19 Infection on the Development of Stroke, Pulmonary Embolism, and Myocardial Infarction: A Retrospective Study.

作者信息

Güven Oya, Karakurt Gökhan, Naser Abdulrahman, Selçuk Hakan, Keleş Dilek V, Gedik Emre, Avsever Mert, Köse Fatih Furkan

机构信息

Department of Emergency Medicine, Kırklareli University Faculty of Medicine, Kırklareli, TUR.

Department of Emergency Medicine, Kırklareli Training and Research Hospital, Kırklareli, TUR.

出版信息

Cureus. 2025 Jan 19;17(1):e77665. doi: 10.7759/cureus.77665. eCollection 2025 Jan.

DOI:10.7759/cureus.77665
PMID:39968441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11835032/
Abstract

INTRODUCTION

This study compares the period during which thromboembolic disease develops after contact with the virus before, during, and after the pandemic.

METHODS

In this study, the medical records of patients with a preliminary diagnosis of myocardial infarction (MI), pulmonary embolism (PE), and ischemic stroke who presented to the Emergency Department before, during, and after the pandemic (when vaccination rates increased) were retrospectively examined. Data on whether these patients had COVID-19 or were vaccinated, the time interval between infection/vaccination and the onset of these conditions, and the prognosis were analyzed.

RESULTS

In the MI group, patients developed embolism the longest after infection and the shortest after vaccination. Among MI patients, the rate of those who received the BioNTech vaccine during the normalization period was higher than that of those who received Sinovac (p = 0.005). In stroke patients, during the pandemic, the time to post-vaccine embolism was shorter (p < 0.001). Additionally, infection and vaccination increased the mortality rate in stroke and PE patients (p < 0.001).

CONCLUSION

This study demonstrates that thromboembolic events can occur at varying rates and durations after exposure to the virus. While the causes of thrombosis are multifactorial, contact with the virus may act as a triggering factor, even if COVID-19 does not have a direct effect.

摘要

引言

本研究比较了大流行之前、期间和之后与病毒接触后血栓栓塞性疾病发生的时间段。

方法

在本研究中,对在大流行之前、期间和之后(接种率上升时)到急诊科就诊的初步诊断为心肌梗死(MI)、肺栓塞(PE)和缺血性中风的患者的病历进行了回顾性检查。分析了这些患者是否感染新冠病毒或接种疫苗、感染/接种与这些疾病发作之间的时间间隔以及预后情况。

结果

在心肌梗死组中,患者感染后发生栓塞的时间最长,接种疫苗后最短。在心肌梗死患者中,正常化期间接种辉瑞疫苗的患者比例高于接种科兴疫苗的患者(p = 0.005)。在中风患者中,在大流行期间,接种疫苗后发生栓塞的时间较短(p < 0.001)。此外,感染和接种疫苗增加了中风和肺栓塞患者的死亡率(p < 0.001)。

结论

本研究表明,接触病毒后血栓栓塞事件可能以不同的发生率和持续时间发生。虽然血栓形成的原因是多因素的,但即使新冠病毒没有直接影响,与病毒接触也可能作为触发因素。

相似文献

1
The Impact of COVID-19 Infection on the Development of Stroke, Pulmonary Embolism, and Myocardial Infarction: A Retrospective Study.新型冠状病毒肺炎感染对中风、肺栓塞和心肌梗死发病的影响:一项回顾性研究
Cureus. 2025 Jan 19;17(1):e77665. doi: 10.7759/cureus.77665. eCollection 2025 Jan.
2
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.法国 75 岁以下成年人接种 COVID-19 疫苗后心肌梗死、中风和肺栓塞的风险。
Ann Intern Med. 2022 Sep;175(9):1250-1257. doi: 10.7326/M22-0988. Epub 2022 Aug 23.
3
Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia.COVID-19 mRNA 疫苗接种后的不良反应:心血管并发症、血栓形成和血小板减少症的系统评价。
Immun Inflamm Dis. 2023 Mar;11(3):e807. doi: 10.1002/iid3.807.
4
No increased incidence of venous thrombosis or pulmonary embolism after SARS-CoV-2 vaccination in Germany.德国的研究表明,接种 SARS-CoV-2 疫苗后静脉血栓栓塞或肺栓塞的发生率没有增加。
Public Health. 2022 Jun;207:14-18. doi: 10.1016/j.puhe.2022.03.004. Epub 2022 Mar 16.
5
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
6
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients.一项关于住院 COVID-19 患者血栓栓塞并发症和结局的系统回顾。
BMC Infect Dis. 2024 May 10;24(1):484. doi: 10.1186/s12879-024-09374-1.
7
The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population.一家单中心重症监护病房(ICU)收治的新冠肺炎患者中血栓栓塞事件的发生率:一项来自马来西亚人群的流行病学研究。
J Pharm Policy Pract. 2025 Feb 5;18(1):2449044. doi: 10.1080/20523211.2024.2449044. eCollection 2025.
8
Thrombotic events following Covid-19 vaccines compared to Influenza vaccines.与流感疫苗相比,新冠疫苗接种后的血栓形成事件。
Eur J Intern Med. 2022 May;99:82-88. doi: 10.1016/j.ejim.2022.03.002. Epub 2022 Mar 9.
9
Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up.新冠疫苗接种后孤立性肺栓塞:2例病例报告及急性肺栓塞后并发症与随访综述
J Community Hosp Intern Med Perspect. 2021 Nov 15;11(6):877-879. doi: 10.1080/20009666.2021.1990825. eCollection 2021.
10
Risk of Stroke, Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, and Death After Retinal Vein Occlusion.视网膜静脉阻塞后发生中风、心肌梗死、深静脉血栓形成、肺栓塞及死亡的风险
Am J Ophthalmol. 2024 Jan;257:129-136. doi: 10.1016/j.ajo.2023.08.022. Epub 2023 Sep 1.

本文引用的文献

1
The Effect of the COVID-19 Pandemic on Emergency Department (ED) Admissions in the Only Hospital of City Center ED.2019年冠状病毒病疫情对市中心唯一一家医院急诊科收治情况的影响
Cureus. 2023 Sep 1;15(9):e44527. doi: 10.7759/cureus.44527. eCollection 2023 Sep.
2
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes.新型冠状病毒肺炎(COVID-19)住院继发静脉血栓栓塞:患者管理与长期结局
Res Pract Thromb Haemost. 2023 May;7(4):100167. doi: 10.1016/j.rpth.2023.100167. Epub 2023 Apr 26.
3
Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.75 岁及以上人群接种 BNT162b2 mRNA COVID-19 疫苗后的心肌梗死、中风和肺栓塞。
JAMA. 2022 Jan 4;327(1):80-82. doi: 10.1001/jama.2021.21699.
4
Outcomes and Spectrum of Major Neurovascular Events Among COVID-19 Patients: A 3-Center Experience.COVID-19患者主要神经血管事件的结局与范围:一项三中心经验
Neurosurg Open. 2020 Sep;1(3):okaa008. doi: 10.1093/neuopn/okaa008. Epub 2020 Jul 17.
5
Comorbidity status of deceased COVID-19 in-patients in Italy.意大利新冠肺炎住院患者的合并症状况。
Aging Clin Exp Res. 2021 Aug;33(8):2361-2365. doi: 10.1007/s40520-021-01914-y. Epub 2021 Jun 24.
6
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge.新冠病毒感染患者出院4个月后持续存在血栓前状态改变。
Blood Adv. 2021 Feb 9;5(3):756-759. doi: 10.1182/bloodadvances.2020003968.
7
Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area.性别差异在 2019 冠状病毒病的易感性、严重程度和结局中的作用:来自美国多元化大都市地区的横断面分析。
PLoS One. 2021 Jan 13;16(1):e0245556. doi: 10.1371/journal.pone.0245556. eCollection 2021.
8
Stroke in COVID-19: A systematic review and meta-analysis.新冠病毒感染相关脑卒中:一项系统评价和荟萃分析。
Int J Stroke. 2021 Feb;16(2):137-149. doi: 10.1177/1747493020972922. Epub 2020 Nov 11.
9
COVID-19: immunopathogenesis and Immunotherapeutics.新型冠状病毒肺炎:免疫发病机制与免疫治疗。
Signal Transduct Target Ther. 2020 Jul 25;5(1):128. doi: 10.1038/s41392-020-00243-2.
10
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.2019冠状病毒病(COVID-19)患者与流感患者发生缺血性卒中的风险比较
JAMA Neurol. 2020 Jul 2;77(11):1-7. doi: 10.1001/jamaneurol.2020.2730.